FDA-BLOOD GLUCOSE › Historical Revision Information
Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use - Draft Guidance for Industry and Food and Drug Administration Staff
Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use - Guidance for Industry and Food and Drug Administration Staff
This document comes with our free Notification Service, good for the life of the document.
This document is available in either Paper or PDF format.
Document Number
FDA-BLOOD GLUCOSE
Revision Level
2018 DRAFT
Status
Draft
Publication Date
Nov. 30, 2018
Page Count
44 pages